BEIJING and CLAREMONT, Calif., Sept. 26 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) today announced that its wholly owned subsidiary, Kiwa Bio-Tech Products (Shandong) Co., Ltd., has completed the first stage of the planned upgrading of its manufacturing facility. Upgrades included building and equipping a fertilizer production line, and installing fermentation equipment for Bacillus.
In April Kiwa announced that the Shandong Provincial Soil and Fertilizer Station authorized Kiwa (Shandong)'s application and registration for two fertilizer registration certificates including one for a water flush fertilizer (applied to plants by mixing with water.)
Earlier this month Kiwa announced that the China Green Food Association of the Agriculture Ministry ("CGFA") has certified six Kiwa bio-fertilizer products as "Green Food CGFA Recommend Brands."
Mr. Wei Li, Chairman and CEO of Kiwa, stated, "With the completion of this stage of the fertilizer manufacturing facility upgrade, the installment of Bacillus fermentation equipment and the registrations of the patents we acquired from Chinese Agriculture University we will be able to better control product quality and significantly improve the competitive advantages of our products."
About Kiwa Bio-Tech Products Group Corporation
The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please visit the Company's website at http://www.kiwabiotech.com .
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.
For more information, please contact:
Kiwa Bio-Tech Products Group Corporation
Yvonne Wang
Tel: +1-626-715-5855
Email: kiwabiotech@gmail.com
Robert Schechter
Equity Communications
Tel: +1-212-499-6809 or +1-646-234-3624
Email: ir4kiwa@hotmail.com
